Your browser doesn't support javascript.
loading
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study.
Broman, Niklas; Feuth, Thijs; Vuorinen, Tytti; Valtonen, Mika; Hohenthal, Ulla; Löyttyniemi, Eliisa; Hirvioja, Tiina; Jalava-Karvinen, Päivi; Marttila, Harri; Nordberg, Marika; Oksi, Jarmo.
Afiliación
  • Broman N; Department of Infectious Diseases, Turku University Hospital, Turku, Finland; University of Turku, Turku, Finland.
  • Feuth T; Division of Medicine, Department of Pulmonary Diseases, Turku University Hospital, Turku, Finland; Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland.
  • Vuorinen T; Institute of Biomedicine, University of Turku, Turku, Finland; Department of Clinical Microbiology, Turku University Hospital, Turku, Finland.
  • Valtonen M; Department of Anaesthesia and Intensive Care, Turku University Hospital, Turku, Finland.
  • Hohenthal U; Department of Infectious Diseases, Turku University Hospital, Turku, Finland; University of Turku, Turku, Finland.
  • Löyttyniemi E; Department of Biostatistics, University of Turku, Finland.
  • Hirvioja T; Department of Infectious Diseases, Turku University Hospital, Turku, Finland; University of Turku, Turku, Finland.
  • Jalava-Karvinen P; Department of Infectious Diseases, Turku University Hospital, Turku, Finland; University of Turku, Turku, Finland.
  • Marttila H; Department of Hospital Hygiene and Infection Control, Turku University Hospital, Turku, Finland.
  • Nordberg M; Åland Central Hospital, Mariehamn, Åland, Finland.
  • Oksi J; Department of Infectious Diseases, Turku University Hospital, Turku, Finland; University of Turku, Turku, Finland. Electronic address: jarmo.oksi@utu.fi.
Clin Microbiol Infect ; 28(6): 844-851, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35259529

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Microbiol Infect Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Microbiol Infect Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Finlandia